# Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

> **NCT03842982** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 362 (estimated)

## Conditions studied

- Ovary Neoplasms
- Ovarian Cancer
- Ovarian Carcinoma

## Interventions

- **DRUG:** HIPEC

## Key facts

- **NCT ID:** NCT03842982
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-03
- **Primary completion:** 2031-02-01
- **Final completion:** 2031-02-01
- **Target enrollment:** 362 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03842982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03842982, "Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03842982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*